A Promising Biotech IPO – And Its Potential Problems
Gossamer Bio is a San Diego-based biotech that is readying for an initial public offering – and with a diverse pipeline including potential treatments for…
Gossamer Bio is a San Diego-based biotech that is readying for an initial public offering – and with a diverse pipeline including potential treatments for…
After experiencing a rough 2018, today’s article notes that “the investment case for emerging markets has vastly improved” – and highlights some specific emerging market…
“This could be gold’s year,” declares one precious metals analyst cited in today’s article on how the yellow metal, the price of which has been…
It’s probably not a surprise to learn that the stocks that were the most adored by analysts at the start of 2018 beat the overall…
When it comes to shorting stocks, the author of today’s article advises that penny promotions may be the best candidates, noting that “The problem with…
If you’re a day trader that doesn’t trade options, you may be missing out on some key benefits they offer. In today’s article, the author…
In regards to the stock of this high-quality pharmaceutical distributor, the author of today’s article declares that it “is not just cheap – it’s incredibly…
At the two year mark of the Trump presidency, and after the stock market surge of 2017 and the return of volatility in 2018 and…
Flow Kana is a California-based company that is part of what today’s article notes is “a relatively new form of cannabis business [that] has emerged:…
What’s the best bet right now when seeking money in gold equities: Gold juniors? Seniors? Intermediates? Explorers? Developers? Royalty companies? Gold itself? What’s the bullish…